Angus Medical

Share

Angus Medical

 •  June 5

Extends BD MAX™ Enteric Panel Portfolio with latest Molecular Test that Targets Infectious Diarrhea According to the Centers for Disease Control and Prevention (CDC), one in six Americans suffers from infection due to food-borne illness each year.1 With the availability of the BD MAX™ extended enteric bacterial panel, the majority of pathogens...

Angus Medical

 •  April 27

Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively Current trends project antimicrobial resistance could cause up to 10 million deaths annually by 2050. Fast and accurate identification of pathogens is often the first step in addressing this issue and with a complete and seamless...

Angus Medical

 •  April 23

Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially Compelling...

Angus Medical

 •  April 4

Expands Infusion Portfolio for Ambulatory, Home Care and Specialty Applications “Our relationship with BD has been very successful over the past two years, and this is the next logical step to elevate our infusion technologies,” said Swi Barak, founder of CME. “This transaction will create new opportunities for our people and our technology that we...

Angus Medical

 •  April 3

Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safety The BD Power in Prevention program leverages critical insights from the company’s Focus on Quality Care program, which since its inauguration in 2012, has conducted more than 20,000 observations at more than 800 facilities...

Angus Medical

 •  March 22

BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017 European Association of Hospital Pharmacists (EAHP) congress, being held in Cannes, France March 22-24. IV medication errors are a serious health care issue.1 They can occur at any stage of the medication delivery process, from prescription...

Angus Medical

 •  February 22

Health care providers and laboratories may be better equipped to test and treat patients during the flu season BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD Veritor™ System Flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new FDA performance...

Angus Medical

 •  January 23

Indication for Congestive Heart Failure on Display at the 2017 Society of Thoracic Surgeons (STS) Meeting A pleural effusion is a collection of fluid that accumulates in the pleural cavity that surrounds the lungs, leaving patients short of breath and affecting their quality of life. When this occurs, the PleurX catheter system provides patients...

Angus Medical

 •  January 20

New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR
AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and advance public health, today announced a global stakeholder initiative to optimize the use of diagnostic tests in the fight against...

Angus Medical

 •  December 15, 2016

New BD Neopak™ 2.25 mL Prefillable Glass Syringe Helps Improve Safety and Convenience for Patients “Through our continued investment in innovation, this new syringe enables biopharmaceutical manufacturers to develop drug-syringe combination products with extended injection intervals. This will provide patients with more time between injections and...